(Q30749300)

26 June 2017

Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity (English)

1 reference

26 June 2017

1 reference

Butz K

1

1 reference

26 June 2017

Denk C

2

1 reference

26 June 2017

Fitscher B

3

1 reference

26 June 2017

Crnkovic-Mertens I

4

1 reference

26 June 2017

Ullmann A

5

1 reference

26 June 2017

Schröder CH

6

1 reference

26 June 2017

Hoppe-Seyler F

7

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 June 2017

1 reference

26 June 2017

20

1 reference

26 June 2017

45

1 reference

26 June 2017

6579-6586

1 reference

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

26 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Hepatitis B virus. The major etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Multifunctional yeast high-copy-number shuttle vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

An artificial cell-cycle inhibitor isolated from a combinatorial library

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Combinatorial protein reagents to manipulate protein function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Intercellular trafficking of VP22-GFP fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Peptide aptamers: powerful new tools for molecular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Targeting cyclin-dependent kinases in Drosophila with peptide aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Constrained peptides as binding entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Protease inhibitors: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Estimates of the worldwide incidence of eighteen major cancers in 1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Immunocytochemical and electron microscopic study of hepatitis B virus antigen and complete particle production in hepatitis B virus DNA transfected HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Characterization of hepatitis B virus core mutants that inhibit viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Assembly and antigenicity of hepatitis B virus core particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Selection of antibodies for intracellular function using a two-hybrid in vivo system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Clinical aspects of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

The crystal structure of the human hepatitis B virus capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Hepatitis B virus capsid particles are assembled from core-protein dimer precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

Hepatitis B virus X protein is not central to the viral life cycle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

7 January 2021

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

7 January 2021

Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

7 January 2021

Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204805

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204805

1 reference

Dimensions Publication ID

26 June 2017

0 references

1 reference